Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.

ABSTRACT:

Introduction

When determining if changes on patient-reported outcome (PRO) scores in clinical trials convey a meaningful treatment benefit, statistical significance tests alone may not communicate the patient perspective. Appraising within-patient changes on PRO scores against established thresholds can determine if improvements or deteriorations experienced by individuals are meaningful. To evaluate the appropriateness of thresholds for interpreting meaningful improvements and deterioration within individuals on the European Organisation for Research and Treatment of Cancer (EORTC) 30-item core instrument (QLQ-C30) and 13-item lung cancer module (QLQ-LC13), a series of psychometric methods were applied to data from a phase III randomized controlled clinical trial in non-small cell

SUBMITTER: Coon CD 

PROVIDER: S-EPMC9585005 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature